Conversion of Amadori products of the Maillard reaction to Nε-(carboxymethyl)lysine by short-term heating: Possible detection of artifacts by immunohistochemistry

Laboratory Investigation

Volumn 82, Issue 6, 2002, Pages 795-807

  Hayashi, Cristina Miki ^a   Nagai, Ryoji ^a   Miyazaki, Kiminori ^a   Hayase, Fumitaka ^b   Araki, Tomohiro ^c   Ono, Tomomichi ^a   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b MEIJI UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ARABINOSE DERIVATIVE; DEOXYGLUCOSE; FORMALDEHYDE; GLYOXAL; HUMAN SERUM ALBUMIN; LYSINE DERIVATIVE; METHYLGLYOXAL; N (CARBOXYMETHYL)LYSINE; SODIUM BOROHYDRIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ARTIFACT; CHEMICAL REACTION; CONTROLLED STUDY; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN; TISSUE FIXATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTIFACTS; BOROHYDRIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; HEAT; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; LYSINE; MAILLARD REACTION; MALE; POLYAMINES; RATS; RATS, WISTAR; SERUM ALBUMIN; SKIN;

EID: 0036278669     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.lab.0000018826.59648.07     Document Type: Article

References (83)

1. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
2. Identification of Ne-carboxymethyllysine as a degradation product of fructoselysine in glycated protein
3. Membrane proteins of human erythrocytes are modified by advanced glycation end products during aging in the circulation
4. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging
5. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
6. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo
7. Detection of an advanced glycosylation product bound to protein in situ
8. Glycation and advanced glycation end-product formation with icodextrin and dextrose
9. Antigen retrieval on formaldehyde-fixed paraffin sections: Its potential drawbacks and optimization for double immunostaining
10. Reaction of formaldehyde with proteins. VI. Cross-linking of amino groups with phenol, imidazole, or indole groups
11. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins
12. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction
13. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina
14. Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a Maillard reaction intermediate
15. Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo
16. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy
17. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: Evidence for the presence of a common structure
18. Evidence against in vivo presence of 2-(2-furoyl)- 4(5)-(2-furanyl)-1H-imidazole, a major fluorescent advanced end product generated by nonenzymatic glycosylation
19. Immunohistochemical study with anti-advanced glycation end-products antibody in murine amyloidosis
20. Identification of N(omega)-carboxymethylarginine as a novel acid-labile advanced glycation end product in collagen
21. Ne-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction
22. Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy
23. Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?
24. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons
25. Novel imidazolones compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in proteins
26. Immunohisto-chemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody
27. Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes
28. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alphaacetylcysteine, and N alpha-acetyllysine, and bovine serum albumin
29. Action des acides amines sur les sucres: Formation des melanoidines par voie methodique
30. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy
31. Immunochemical detection of advanced glycosylation end products in vivo
32. Hemoglobin-AGE: A circulating marker of advanced glycosylation
33. Immunohistochemical localization of advanced glycation end products in pulmonary fibrosis
34. Advanced glycation end products of the Maillard reaction in aortic pepsin-insoluble and pepsinsoluble collagen from diabetic rats
35. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage
36. Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation
37. Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat
38. Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds
39. Beta 2-mcroglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis
40. Identification of pentosidine as a native structure for advanced glycation end products in b2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis
41. Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction
42. Immunohistochemical localization of beta 2-microglobulin and advanced glycation end products in amyloid-enriched carpal tunnel ligament
43. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product
44. Conversion of Amadori product of Maillard reaction to Nepsilon-(carboxymethyl)lysine in alkaline condition
45. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor
46. Crosslines A and B as candidates for the fluorophores in age-and diabetes-related cross-linked proteins, and their diacetates produced by Maillard reaction of a-N-acetyl-L-lysine with D-glucose
47. Acid-stable fluorescent advanced glycation end products: Vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose
48. Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus
49. Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat
50. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD
51. Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons
52. Mechanism of formation of the putative advanced glycosylation end product and protein cross-link 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole
53. Methylglyoxal modification of protein
54. Aging of proteins: Isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose
55. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins
56. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions
57. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases
58. Structure elucidation of a senescence cross-link from human extracellular matrix
59. Antigen retrieval immunohistochemistry: Past, present, and future
60. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
61. Advanced glycosylation end products in adrenal lipofuscin
62. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease
63. Advance Maillard reaction end products are associated with Alzheimer disease pathology
64. Measurement of protein using bicinchoninic acid
65. Localization in human diabetic peripheral nerve of N(epsilon)-carboxymethyllysine-protein adducts, an advanced glycation endproduct
66. Immunohistochemical staining of renal biopsy samples in patients with diabetic nephropathy in non-insulin dependent diabetes mellitus using monoclonal antibody to advanced glycation end products
67. Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains
68. Comparative study of antigen retrieval heating methods: Microwave, microwave and pressure cooker, autoclave, and steamer
69. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and anti-proliferative chemotherapy
70. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
71. Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions
72. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids
73. Advanced glycation end products contribute to amyloidosis in Alzheimer disease
74. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose
75. Pathways of formation of glycoxidation products during glycation of collagen
76. Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation
77. Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction
78. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure
79. Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress
80. Reactivities of D-glucose and D-fructose during glycation of bovine serum albumin
81. Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation
82. Formation of reactive intermediates from Amadori compounds under physiological conditions